True North Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,819
Closed -$288K 256
2025
Q3
$288K Buy
+3,819
New +$262K 0.05% 177
2024
Q2
Sell
-2,686
Closed -$214K 200
2024
Q1
$214K Sell
2,686
-47
-2% -$3.59K 0.06% 182
2023
Q4
$216K Sell
2,733
-194
-7% -$13.8K 0.06% 176
2023
Q3
$204K Buy
2,927
+27
+0.9% +$1.91K 0.06% 188
2023
Q2
$200K Sell
2,900
-7,800
-73% -$555K 0.06% 198
2023
Q1
$795K Sell
10,700
-1,883
-15% -$158K 0.23% 95
2022
Q4
$1.17M Hold
12,583
0.4% 67
2022
Q3
$1.2M Sell
12,583
-884
-7% -$87.5K 0.39% 66
2022
Q2
$1.25M Buy
13,467
+1,755
+15% +$171K 0.39% 65
2022
Q1
$1.19M Sell
11,712
-253
-2% -$26.6K 0.32% 75
2021
Q4
$1.23M Buy
11,965
+1
+0% +$92 0.21% 98
2021
Q3
$1.01M Sell
11,964
-52
-0.4% -$4.36K 0.2% 103
2021
Q2
$1M Buy
12,016
+45
+0.4% +$3.69K 0.21% 93
2021
Q1
$900K Buy
11,971
+3,000
+33% +$219K 0.21% 92
2020
Q4
$612K Buy
8,971
+4
+0% +$260 0.16% 107
2020
Q3
$523K Sell
8,967
-405
-4% -$25.2K 0.15% 106
2020
Q2
$608K Buy
+9,372
New +$590K 0.15% 105

Other funds holding CVS

True North Advisors's CVS Position: Q4 2025 in Review

True North Advisors sold out of CVS Health (CVS) in Q4 2025, closing a stake of 3,819 shares — an estimated $288K sold.

True North Advisors first reported a position in CVS in Q2 2020 and held it in 17 quarters. The position peaked at $1.25M in Q2 2022. 1,948 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • True North Advisors reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
  • True North Advisors sold 3,819 CVS Health shares in Q4 2025, an estimated $288K.
  • True North Advisors first reported a position in CVS Health in Q2 2020 and held it in 17 quarters.
  • True North Advisors's CVS Health position peaked at $1.25M in Q2 2022.
  • 1,948 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on True North Advisors's 13F filing for Q4 2025, filed 22 Jan 2026.